NOVA Advantage VasSol’s NOVA software provides noninvasive intracranial hemodynamic analysis, offering a differentiator in stroke prevention, aneurysm monitoring, and neurovascular care which could pair well with hospitals and imaging centers investing in advanced diagnostics.

Small Team, Scale With a lean 2–10 employee base, VasSol presents a growth opportunity for strategic partnerships, channel plays, and white-label collaborations with larger medical device distributors and integrators to accelerate market reach.

Industry Fit Target medical device manufacturers and end users in neurology, neurosurgery, and interventional radiology sectors who require quantitative blood flow analytics to enhance decision support, surgical planning, and patient outcomes.

Revenue Potential Given current revenue in the low to mid single digits of millions, there is room to upsell to larger hospital networks and academic medical centers through bundles, service contracts, and expanded analytics modules.

Digital Presence VasSol’s digital stack and online presence suggest opportunities for marketing automation, partner portals, and enterprise sales enablement integrations to improve lead capture, qualification, and deal velocity.